.svg){kind=small}
Apr-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the competitive cannabis oil category, MediPharm Labs has shown remarkable consistency and dominance, especially in the Alberta and Saskatchewan markets where it secured the top ranking from January to April 2024. This achievement is underscored by its sales performance, with a notable increase in Alberta from 364,357 in January to 583,943 in April, indicating a strong upward trend and growing consumer preference. However, in British Columbia and Ontario, while the brand consistently held the second position across the same period, this suggests a strong presence but also room for growth to challenge for the top spot. The steady rankings across these provinces highlight MediPharm Labs' significant impact and its ability to maintain a leading position in the highly competitive oil category.
Despite the impressive rankings, the absence of MediPharm Labs from the top 30 brands in any state or province outside of those mentioned for the oil category could be viewed as an area for expansion or increased marketing efforts. The detailed sales figures, such as the gradual increase in British Columbia from 143,826 in January to 189,754 in April, while showing positive growth, also hint at a slower pace compared to Alberta, suggesting market dynamics and consumer preferences could be influencing factors. This performance analysis across different regions not only showcases MediPharm Labs' strengths in maintaining top rankings where it competes but also underscores the potential for broader market penetration and the need to address areas where it's not currently a top contender.
Competitive Landscape
In the competitive landscape of the cannabis oil category in Alberta, MediPharm Labs has maintained a leading position, consistently ranking 1st from January to April 2024. This dominance is underscored by its sales, which have shown a significant upward trajectory, outpacing competitors by a wide margin. Notably, Frank, holding the 2nd rank during the same period, has seen a steady increase in sales but remains considerably behind MediPharm Labs in both rank and sales volume. Another notable competitor, Tweed, entered the top 5 in March and maintained its position in April, indicating a growing presence in the market. However, Tweed's sales, while improving, are still far lower than those of MediPharm Labs. This analysis highlights MediPharm Labs' strong market position and its ability to maintain a significant lead over its competitors in terms of sales and rank within the Alberta oil category.
Notable Products
In April 2024, MediPharm Labs saw its CBN:THC 1:2 Nighttime Formula Oil (30ml) maintain its position as the top-selling product with 8,977 units sold, continuing its streak from the previous three months. The THC 30 Regular Formula Oil (30ml) climbed to the second spot, showcasing a consistent increase in sales and improving its rank from the third position in March. The CBN:CBD 1:2 Relax Formula Oil (30ml) was ranked third, slightly dropping from its previous second-place in March, indicating a shift in consumer preference towards THC-dominant products. The CBD 50 Plus Olive Formula Oil (30ml) and the CBG/CBD 1:2 Advanced Formula Oil (30ml) remained steady in their fourth and fifth positions, respectively, showing stable demand among their niche. This ranking change, especially in the top three products, reflects a dynamic market with evolving consumer preferences within the MediPharm Labs offerings.
Top Selling Cannabis Brands
